The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.90
Bid: 133.60
Ask: 133.90
Change: -2.70 (-1.98%)
Spread: 0.30 (0.225%)
Open: 135.30
High: 138.60
Low: 133.50
Prev. Close: 136.60
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Notes Offering

11 Mar 2024 07:36

RNS Number : 3138G
Aston Martin Lagonda Glob.Hldgs PLC
11 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,

DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

OF AMERICA, CANADA, JAPAN OR AUSTRALIA

 

11 March 2024

 

Aston Martin Lagonda Global Holdings plc

("Aston Martin Lagonda", the "Company" or the "Group")

 

Launch of Notes Offering and New Revolving Credit Facility by its Subsidiaries

 

Aston Martin Lagonda Global Holdings plc (the "Company") announces that its subsidiary, Aston Martin Capital Holdings Limited (the "Issuer"), is today launching an offering of £1,140 million (equivalent) aggregate principal amount of senior secured notes due 2029 (the "Notes").

 

The Company further announces that the issuer has agreed with certain of its existing lenders to enter into a new super senior revolving credit facility agreement, pursuant to which the lenders have agreed to increase their binding commitments by circa £70 million to £170 million, subject to consummation of the Notes offering.

 

If completed, the proceeds from the offering of the Notes, together with cash on balance sheet, will be used to redeem in full the Issuer's existing senior secured notes and second lien split coupon notes, to repay in full the borrowings under its existing revolving credit facility and to pay expenses and fees in connection with the transactions.

 

In connection with the launch, the Company has today published on its website its Financial Statements for the financial year ended 31 December 2023 which can be downloaded in pdf format at www.astonmartinlagonda.com/investors/results-and-presentations. The full Annual Report and Accounts for the financial year ended 31 December 2023 is expected to be published on 8 April 2024.

 

This announcement contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation No. 596/2016 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for releasing this announcement on behalf of the Company is Liz Miles, Company Secretary.

 

Enquiries

Investors and Analysts

James Arnold Head of Investor Relations +44 (0) 7385 222347

james.arnold@astonmartin.com

 

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

 

Media

Kevin Watters Director of Communications +44 (0) 7764 386683

kevin.watters@astonmartin.com

 

Paul Garbett Head of Corporate and +44 (0) 7501 380799

Brand Communications paul.garbett@astonmartin.com

Cautionary Statement

 

The Notes will be offered only to qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons outside the United States pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act"), subject to prevailing market and other conditions. There is no assurance that the offering will be completed or, if completed, as to the terms on which it is completed. The Notes to be offered have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold, directly or indirectly, in the United States or to or for the account or benefit of U.S. persons, as such term is defined in Regulation S of the Securities Act, absent registration or unless pursuant to an applicable exemption from the registration requirements of the Securities Act and any other applicable securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

The Notes are not intended to be offered, sold or otherwise made available to, and should not be offered, sold or otherwise made available to, any retail investor in the European Economic Area ("EEA") or in the United Kingdom. For these purposes, a "retail investor" in the EEA means a person who is one (or more) of: (i) a "retail client" as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"), (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II or (iii) not a "qualified investor" as defined in Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation"). A "retail investor" in the UK means a person who is one (or more) of: (i) a "retail client" as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"), (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (as amended, "FSMA") and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the EUWA or (iii) not a "qualified investor" as defined in Article 2 of the Prospectus Regulation, as it forms part of UK domestic law by virtue of the EUWA (the "UK Prospectus Regulation").

 

This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the Prospectus Regulation and the UK Prospectus Regulation. The offer and sale of the Notes will be made pursuant to an exemption under the Prospectus Regulation and the UK Prospectus Regulation from the requirement to produce a prospectus for offers of securities.

 

The manufacturer target market (MIFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs or UK PRIIPs key information document (KID) has been prepared as the Notes are not available to retail clients in the EEA or in the United Kingdom.

 

This communication does not constitute an offer of securities to the public in the United Kingdom and is being distributed only to, and is directed only at persons who are "qualified investors" (as defined in the UK Prospectus Regulation) who are (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"), or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) outside the United Kingdom; or (iv) persons to whom it would otherwise be lawful to distribute it, all such persons together being referred to as "Relevant Persons"). In the UK, any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this communication or any of its contents.

 

Forward-Looking Statements

 

This press release may include forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "intends," "may," "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding the Issuer's or its affiliates' intentions, beliefs or current expectations concerning, among other things, the Issuer's or its affiliates' results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which they operate. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and that the Issuer's or its affiliates' actual results of operations, financial condition and liquidity, and the development of the industries in which they operate may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition, even if the Issuer's or its affiliates' results of operations, financial condition and liquidity, and the development of the industries in which they operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODDFLBFZXLXBBE
Date   Source Headline
31st May 20239:18 amRNSHolding(s) in Company
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding
30th May 20238:31 amRNSDirector/PDMR Shareholding
26th May 20239:30 amRNSLTIP and Deferred Bonus Awards
26th May 20239:00 amRNSIssue of Equity and PDMR share awards
26th May 20237:00 amRNSAdmission of New Shares and Total Voting Rights
25th May 20233:05 pmRNSListing Application
18th May 20237:07 amRNSSubstantial Investment in Aston Martin by Geely
17th May 202312:26 pmRNSVoting results of Annual General Meeting
3rd May 20232:37 pmRNSESEF Annual Report
3rd May 20237:00 amRNSQ1 2023 financial results
13th Apr 20239:45 amRNSNotice of AGM
13th Apr 20237:00 amRNSResignation of Non-executive Director
20th Mar 20238:00 amRNSAnnual Financial Report
2nd Mar 20231:01 pmRNSDirector/PDMR Shareholding
1st Mar 20237:00 amRNSFinal Results
23rd Dec 202210:58 amRNSHolding(s) in Company
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20228:30 amRNSHolding(s) in Company
15th Dec 20228:00 amRNSHolding(s) in Company
12th Dec 202212:37 pmRNSHolding(s) in Company
22nd Nov 20229:12 amRNSHolding(s) in Company
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSHolding(s) in Company
9th Nov 20223:33 pmRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSHolding(s) in Company
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
3rd Nov 20222:33 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNS3rd Quarter Results
1st Nov 20227:00 amRNSDirectorate Change
10th Oct 20221:55 pmRNSResults and Settlement of Tender Offer
30th Sep 20223:59 pmRNSHolding(s) in Company
30th Sep 20223:57 pmRNSDirector/PDMR Shareholding
30th Sep 20223:52 pmRNSDirector/PDMR Shareholding
30th Sep 20223:43 pmRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:03 amRNSSuccessful completion of £654m capital raise
30th Sep 20227:00 amRNSHolding(s) in Company
29th Sep 20224:00 pmRNSAppointment of Non-executive Director
29th Sep 20223:05 pmRNSDirector/PDMR Shareholding
29th Sep 20221:36 pmRNSHolding(s) in Company
29th Sep 20228:37 amRNSTender offer for portion of outstanding notes
28th Sep 202212:01 pmRNSRump Placing Announcement
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.